BIONTECH

Serial Number 79263465
Registration 6066335
700

Registration Progress

Application Filed
Apr 5, 2019
Under Examination
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered
Jun 2, 2020

Attorney Assistance

Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200602)
Due: Jun 02, 2026 151 days

Trademark Image

BIONTECH

Basic Information

Serial Number
79263465
Registration Number
6066335
Filing Date
April 5, 2019
Registration Date
June 2, 2020
Published for Opposition
March 17, 2020
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 2, 2020
Registration
Registered
Classes
001 005 042 044

Rights Holder

BioNTech SE

94
Address
An der Goldgrube 12
55131 Mainz
DE

Ownership History

BioNTech SE

Original Applicant
94
DE

BioNTech SE

Owner at Publication
94
DE

BioNTech SE

Original Registrant
94
DE

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

Next Deadline
151 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20200602)
Due Date
June 02, 2026
Grace Period Ends
December 02, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Jun 2, 2025 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Feb 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 24, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Feb 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 24, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 24, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 15, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 18, 2020 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 28, 2020 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 28, 2020 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 2, 2020 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 2, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2020 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 26, 2020 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 26, 2020 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 13, 2020 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Feb 11, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 7, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 6, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 5, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 5, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 24, 2019 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Aug 30, 2019 RFNT P REFUSAL PROCESSED BY IB Loading...
Aug 15, 2019 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Aug 15, 2019 RFRR P REFUSAL PROCESSED BY MPU Loading...
Jul 26, 2019 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 23, 2019 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Jul 22, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 18, 2019 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemicals used in industry and science, in particular for use in biotechnology, pharmaceutics, medicine and veterinary medicine
Class 005
Pharmaceutical and veterinary preparations, namely, preparations for the prevention and treatment of proliferative diseases, cancers, infectious diseases, autoimmune diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; vaccines, namely, DNA-based and RNA-based vaccines, adjuvant preparations for use with vaccines, nucleic acids sequences, proteins, and chemical reagents for medical and veterinary purposes, protein conjugates, peptides featuring antibodies and tumour markers; cell-based immunotherapeutic treatment by way of genetically modified cells, medicated serums for the treatment of proliferating diseases, cancers, infectious diseases, and autoimmune diseases, attenuated viruses and particles similar to viruses, namely, encapsulated nucleic acids; diagnostic reagents and diagnostic preparations for medical purposes
Class 042
Scientific research and development in the field of molecular biology, biotechnology, pharmaceutics, immunology and oncology, in particular research and development in the field of medical and veterinary diagnostics and therapy using molecular biological, genetic engineering and biotechnological methods, and scientific research related to screening for pharmaceutically active compounds; scientific research and development of diagnostic methods and test processes; scientific research and development related to technical planning and conducting of projects in the field of the supplying of medicines; scientific consultancy services in the field of research and development of therapies and medical preparations; providing of scientific expertise in the nature of scientific study and research in the field of medicine; scientific research and development for medical and veterinary purposes; conducting and evaluating medical and pharmaceutical studies, namely, testing, analysis and evaluation of goods/services of others to determine conformity with certification standards
Class 044
Medical services; providing medical care services and consultation related thereto; urgent medical care centers; pharmaceutical and medical consultancy; providing healthcare information and advisory services in the healthcare field; medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; medical and pharmaceutical consultation; all the aforesaid services other than in the field of bione therapy or other types of therapy combined with bione therapy

Additional Information

Design Mark
The mark consists of the stylized wording "BIONTECH".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 042 044